Bone Marrow Cancer Drug May Effective for Pancreatic Tumors Treatment
New Treatment Hope for Aggressive Pancreatic Tumors treatment Pancreatic ductal adenocarcinoma, a particularly aggressive variant of pancreatic cancer, has long posed a formidable challenge to medical science for Pancreatic Tumors treatment, boasting a disheartening 5-year survival rate of less than 10%. However, a ray of hope emerges from a recent study featured in Nature Cancer,…